Lucence Company
Lucence Diagnostics is a precision medicine company improving cancer care globally through its liquid biopsies built on its ultra-sensitive sequencing technology.
Technology:
diagnostics
Industry:
Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
Headquarters:
Singapore
Founded Date:
42461
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
5
Total Funding:
$29.2M
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019-11-20
Last Funding Type:
Series A
Register and Claim Ownership